Profile of HER2/neu Expression in Surface Epithelial Ovarian Tumours: A Clinicomorphological Study

Introduction: Surface Epithelial Ovarian Tumours (SEOT) are most prevalent tumours and account for about two third of all ovarian cancers. Survival of ovarian carcinoma is poor despite optimal surgical and chemotherapeutic management. Evaluation of new diagnostic and prognostic Immunohistochemical (...

Full description

Bibliographic Details
Main Authors:	Abbirami Rajarajan, Kalaivani Amitkumar, Muthu Sudalaimuthu
Format:	Article
Language:	English
Published:	JCDR Research and Publications Private Limited 2023-02-01
Series:	Journal of Clinical and Diagnostic Research
Subjects:	cancer antigen 125 human epidermal growth factor receptor 2 immunohistochemical
Online Access:	https://jcdr.net/articles/PDF/17547/61283_CE[Ra1]_F(IS)_PF1(JY_KM)_Re-redo_PFA(KM)_PB(OM)_PN(OM).pdf

Similar Items

Pilocytic Astrocytoma Arising in Ovarian Mature Cystic Teratoma: An Unusual Neuroectodermal Malignant Transformation Occurring in Pregnant Female
by: Kalaivani Amitkumar, et al.
Published: (2023-01-01)

Study the technical validity and feasibility of serum HER-2/Neu and its correlation with tissue HER-2 status in female breast cancer patients only
by: Sufia Ahmad Khan, et al.
Published: (2023-11-01)

Human Epidermal Growth Factor Receptor 2 (HER-2/neu)-Directed Therapy for Rare Metastatic Epithelial Tumors with HER-2 Amplification
by: Daniel Sanghoon Shin, et al.
Published: (2016-06-01)

Immunohistochemical expression of estrogen receptors, progesterone receptors, and human epidermal growth-factor receptor 2/neu in epithelial ovarian tumors
by: Zaineb Y Mohieldin, et al.
Published: (2022-01-01)

Expression of Her2/neu in Urothelial Neoplasms and its Association with Histopathological Prognostic Parameters
by: Madhulatha Guntimadugu, et al.
Published: (2023-01-01)

Significance of HER2/neu Expression in Oesophageal Carcinomas and its Association with the Histopathological Grading
by: Saranya, et al.
Published: (2022-09-01)

CA-125 and Ceruloplasmin Levels in Ovarian Cancer Patients
by: Mangala Hegde, et al.
Published: (2015-09-01)

Quantitative Measurement of Progesterone Receptor Immunohistochemical Expression to Predict Lymph Node Metastasis in Endometrial Cancer
by: Yu-Yang Hsiao, et al.
Published: (2022-03-01)

Ligand-based adoptive T cell targeting CA125 in ovarian cancer
by: Haihong Zhao, et al.
Published: (2023-09-01)

The Role of Salivary and Serum Ca125 and Routine Blood Tests in Patients with Ovarian Malignancies
by: Ante Vuković, et al.
Published: (2021-01-01)

Emerging trends in the immunohistochemical characteristics of breast carcinomas in Uyo: A Niger-Delta region of Nigeria and a review of the literature
by: Emem Imo Akpanudo, et al.
Published: (2022-01-01)

Osteopontin as a tumor marker in ovarian cancer
by: Shikha Rani, et al.
Published: (2022-01-01)

Comparing the Diagnostic Value of the Risk of Ovarian Malignancy Algorithm and CA125 in Patients with Ovarian Mass
by: Alireza Rezaee, et al.
Published: (2019-07-01)

IMMUNOHISTOCHEMICAL DETERMINATION OF TUMOR-ASSOCIATED ANTIGENS IN AMELOBLASTOMA AND ODONTOGENIC CYSTS
by: B.K.H. Moghadam, et al.
Published: (1997-06-01)

Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors
by: Ke Huang, et al.
Published: (2023-02-01)

Molecular Recognition and Quantification of HER-3, HER-4 and HRG-α in Whole Blood and Tissue Samples Using Stochastic Sensors
by: Raluca-Ioana Stefan-van Staden, et al.
Published: (2022-10-01)

Exploring the Role of Pleurotus Ostreatus as an Ointment Formulation in Inducing Wound Healing in Mice Skin
by: Ola Adil Abdulhameed, et al.
Published: (2024-01-01)

Reckoning the Status of HER2/neu Protein and Oncogene in Breast Cancer Specimens: Comparison of IHC Assay with FISH Assay at a Tertiary Care Centre, West India
by: Ranjana Solanki, et al.
Published: (2023-04-01)

Comparison of Serum CA-125 Level in Ruptured and Unruptured Tubal Pregnancies in Yazd/Iran during 2001-2006
by: L Sekhavat, et al.
Published: (2009-07-01)

Risk of Ovarian Malignancy Algorithm and Pelvic Mass Score for the prediction of malignant ovarian tumors: a prospective comparative study
by: Ali Mohamed A., et al.
Published: (2024-02-01)

Immunohistochemical Coexpression of VEGF and CD34 in Ameloblastoma
by: Wasan H. Younis, et al.
Published: (2008-04-01)

Immunohistochemical Survey of Invasive Ductal Carcinoma of the Breast, using ER, PR, HER2 and KI-67 biomarkers, in Uyo, Nigeria
by: Eziagu UB, et al.
Published: (2022-09-01)

Could Ovarian Cancer Prediction Models Improve the Triage of Symptomatic Women in Primary Care? A Modelling Study Using Routinely Collected Data
by: Garth Funston, et al.
Published: (2021-06-01)

Comparison of Immunohistochemical Methods (IHC) and Fluorescent in Situ Hybridization (FISH) in the Detection of HER2 /Neu Gene in Kurdish Patients with Breast Cancer in Western Iran
by: Mozaffar Aznab, et al.
Published: (2022-10-01)

Histopathological evaluation of estrogen receptors, progesterone receptors, and human epidermal growth factor Receptor-2/Neu expressions in breast carcinoma and their correlations with other prognostic factors: A hospital-based study
by: Hena Kawsar, et al.
Published: (2022-01-01)

Biomarkers in Ovarian Pathology: From Screening to Diagnosis. Review of the Literature
by: Miguel Ángel Elorriaga, et al.
Published: (2021-10-01)

Hormone receptors over the last 8 years in a cancer referral center in India: What was and what is?
by: Shet Tanuja, et al.
Published: (2009-04-01)

Evaluation of triple hormonal content (ER, PR, and HER\2neu)of breast cancer specimens obtained from breast cancer patients using tru-cut biopsy
by: Mustafa H. Jasim, et al.
Published: (2016-10-01)

The impact of nitric oxide on HER family post-translational modification and downstream signaling in cancer
by: Ciara E. O’Neill, et al.
Published: (2024-03-01)

The application of HER2 and CD47 CAR-macrophage in ovarian cancer
by: Yizhao Chen, et al.
Published: (2023-09-01)

Recent Advances in Surface Plasmon Resonance (SPR) Technology for Detecting Ovarian Cancer Biomarkers
by: Vikneswary Ravi Kumar, et al.
Published: (2023-11-01)

Skin metastases in ovarian malignancy: A case report with literature review
by: Vibha Rani Pipal, et al.
Published: (2023-01-01)

Loss of Human Epidermal Receptor 2 Expression in Formalin-Fixed Paraffin-Embedded Breast Cancer Samples and the Rescuing Effect of Enhanced Antigen Retrieval and Signal Amplification
by: Xiuli Ma, et al.
Published: (2023-12-01)

Rapidly progressing malignant phyllodes tumor of the prostate with normal prostate-specific antigen levels: A case report
by: Xiaorong Zhang, et al.
Published: (2020-01-01)

Over Kanserli Hastalarda CA-125 ve Seruloplazmin Düzeyleri
by: Mangala HEGDE, et al.
Published: (2015-09-01)

Evaluation of the Expression Intensity of Glucose Transporter-1 Marker and its Diagnostic Value in Differentiating Between Borderline and Malignant Ovarian Epithelial Tumors
by: Siamak Naji Hadadi, et al.
Published: (2023-04-01)

Extracellular domain of HER2 heterologous expression in bacteria
by: V. V. Dolgikh, et al.
Published: (2013-12-01)

Single and combined use of red cell distribution width, mean platelet volume, and cancer antigen 125 for differential diagnosis of ovarian cancer and benign ovarian tumors
by: Yuan-yuan Qin, et al.
Published: (2018-01-01)

Synthesis and biological evaluation of 125I-erythropoietin as a potential radiopharmaceutical agent for tumours
by: Gonçalo dos Santos Clemente, et al.
Published: (2011-03-01)

The role of Wilm’s Tumor1 immunohistochemical marker in surface epithelial ovarian tumors
by: Muna I. AL Hafedh, et al.
Published: (2015-07-01)